BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33595252)

  • 21. Parasitic myoma after laparoscopic morcellation: a systematic review of the literature.
    Van der Meulen JF; Pijnenborg JM; Boomsma CM; Verberg MF; Geomini PM; Bongers MY
    BJOG; 2016 Jan; 123(1):69-75. PubMed ID: 26234998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Power Morcellation of Unsuspected High-grade Leiomyosarcoma Within an Inflated Containment Bag: 2-year Follow-up.
    Boruta DM; Shibley T
    J Minim Invasive Gynecol; 2016; 23(6):1009-11. PubMed ID: 27393286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
    Parker W; Pritts E; Olive D
    J Minim Invasive Gynecol; 2015; 22(4):696-7. PubMed ID: 25623370
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term sequelae of unconfined morcellation during laparoscopic gynecological surgery.
    Cohen A; Tulandi T
    Maturitas; 2017 Mar; 97():1-5. PubMed ID: 28159054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
    Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
    Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
    Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for morcellation in gynecologic surgery.
    Parker WH
    Curr Opin Obstet Gynecol; 2018 Feb; 30(1):75-80. PubMed ID: 29251677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
    Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
    J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Port site parasitic leiomyoma after laparoscopic myomectomy: a case report and review of the literature.
    Oindi FM; Mutiso SK; Obura T
    J Med Case Rep; 2018 Nov; 12(1):339. PubMed ID: 30428912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morcellation of the Uterus: Is There Any Place?
    Halaska MJ; Gracia M; Laky R; Zapardiel I
    Curr Oncol Rep; 2020 Jun; 22(7):68. PubMed ID: 32514869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic power morcellation of presumed fibroids.
    Brolmann HA; Sizzi O; Hehenkamp WJ; Rossetti A
    Minerva Ginecol; 2016 Jun; 68(3):352-63. PubMed ID: 26799759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
    Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
    J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
    Tulandi T; Leung A; Jan N
    J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Being the ultimate travel companion of a patient with uterine leiomyosarcoma.
    Grignani G; Merlini A; Aliberti S
    Future Oncol; 2022 Sep; 18(29s):17-23. PubMed ID: 36169665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
    Smits RM; De Kruif JH; Van Heteren CF
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
    Ludwin A; Gawron I; Pityński K
    Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.
    Siedhoff MT; Kim KH
    J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy.
    Hur HC; King LP; Klebanoff MJ; Hur C; Ricciotti HA
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():122-127. PubMed ID: 26520875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.